Mohsen Janghorbani Professor of Epidemiology Department …...5 coronary heart disease among married...

1

CURRICULUM VITAE

Mohsen Janghorbani

Professor of Epidemiology

Department of Epidemiology and Biostatistics

School of Public Health

Isfahan University of Medical Sciences

Isfahan, Iran

2

Personal Information

Family Name: Janghorbani

First Name: Mohsen

Father Name: Mostafa

Mother Name: Amin

Date of Birth: April 23, 1950

Nationality: Iranian

Marital Status: Married

Number of Children: 1 (son)

Job Title: Professor

Organisation: Isfahan University of Medical Sciences, Isfahan, Iran

Mailing Address: Department of Epidemiology and Biostatistics, School of Public

Health, Isfahan University of Medical Sciences, Isfahan, Iran

Telephone: (+98)311- 2334893

Fax: (+98)311-6682509

Mobile:09113147467

E-mail: [email protected]

Education

Institute From to Field Degree

Ahwaz University, Iran 1971-1975 Radiology B.Sc.

Shiraz University, Iran 1975-1977 Epidemiology MSc

Glasgow University, UK 1984-1988 Epidemiology PhD

Karolinska Institute, Sweden 1992-1992 Advanced

Epidemiology and

Biostatistics

Certificate

Employment

Institute From to Position Field Duty

Uremia University 1977-78 Instructor Epidemiology Teaching and research

Kerman University 1978-1988 Instructor Epidemiology Teaching and research

Kerman University 1988-1992 Assistant Prof. Epidemiology Teaching and research

Kerman University 1992-1999 Associate Prof. Epidemiology Teaching and research

Isfahan University 1999-2000 Associate Prof. Epidemiology Teaching and research

Isfahan University 2000- Now Professor Epidemiology Teaching and research

University of Hong

Kong

2000-2001 Research

Fellow

Epidemiology Research

University of

Plymouth, UK

2004-2005 Fellow Scientist Epidemiology Research

Harvard School of

Public Health

2005-2006 Visiting

Scientist

Epidemiology Research

3

Awards

1. Winner of the prize of best translated book, 1997 Kerman Iran .

2. Winner of the prize of outstanding researcher, 1998, Kerman University of

Medical Science, Iran.

3. Winner of the prize of outstanding researcher, 2001, Isfahan University of


4. Winner of the prize of outstanding researcher, 2002 Isfahan University of


5. Winner of the prize of outstanding researcher of Isfahan University of Medical

Sciences, 2003 Isfahan, Iran.

6. Winner of the prize of 12th Razi Feastival, 2006.



8. Winner of the prize of outstanding teacher of Isfahan University of Medical

Sciences, 2007 Tehran, Iran.




Sciences, 2009, Isfahan, Iran.

11. Winner of the prize of outstanding researcher of Isfahan Province, 2009,

Isfahan, Iran.







15. Winner of the prize of 18th Razi Feastival, 2012.

Publications

A: Research Publications

1. Janghorbani M, Zhianpour M. An epidemiological study of tuberculosis in

children under 10 years of age in Kavar area, Fars Province. Iran J Med Sciences

1980; 11:61-72.

2. Janghorbani M. Traffic casualties in Shiraz. Iran. J Surgery 1980; 3:131-145

3. Janghorbani M, Hedley AJ, Zhianpour M, Jones RB, Gilmur WH. Blood

pressure components as predictor of ischaemic heart disease mortality in west of

Scotland. Medical Journal of Islamic Republic of Iran 1991; 5:117-123.

4. Janghorbani M, Hedley AJ, Jones RB, Gilmur WH, Gillis CR, Zhianpour M.

4

Blood pressure components as predictor of stroke mortality in west of Scotland.

Medical Journal of Islamic Republic of Iran 1990; 4:13-19.

5. Janghorbani M, Hedley AJ, Jones RB Gilmur WH, Zhianpour M. Trends in

mortality from stroke in Scotland 1950-1986. Public Health 1992; 106: 343-350.

6. Janghorbani M, Hedley AJ, Jones RB, Gilmur WH, Zhianpour M. Is the

association between blood glucose level and “all causes” and cardiovascular

mortality risk depends on body mass index. Medical Journal of Islamic Republic

of Iran 1992, 6:205-212.

7. Janghorbani M, Hedley AJ, Jones RB, Zhianpour M, Gilmour WH. Gender

differential in all cause and cardiovascular disease mortality. Int J Epidemiol

1993; 22:1056-1063.

8. Janghorbani M, Daie-Parizi MH, Ghorbani K. Measles epidemics in Kerman,

Iran. Public Health 1993; 107:79-87.

9. Daie-Parizi MH, Janghorbani M. Measles epidemics in Kerman. Medical

Journal of Islamic Republic of Iran 1993, 604:249-254.

10. Janghorbani M, Jones RB, Hedley AJ. Using the Community Health Index,

general practitioner records and the National Health Service Central Registry for

a 14 year follow-up of a middle aged in the west of Scotland. Health Bulletin

1993; 51:28-33.

11. Janghorbani M, Jones RB, Gilmour WH, Hedley AJ, Zhianpour M. A

prospective population-based study of gender differential in mortality from

cardiovascular disease and “all-causes” in asymptomatic hyperglycaemic. Journal

of Clinical Epidemiology 1994; 47:397-405.

12. Keshavarz-Vallian H, Janghorbani M. The efficiency of malaria screening

program among Afghan refugees in Kerman, Iran. Medical Journal of Islamic

Republic of Iran 1994, 8:167-171.

13. Janghorbani M, Jones RB, Hedley AJ. Is a high casual blood glucose value a

predictor of later diabetes? Hamdard Medicus 1994; 37:52-57.

14. Janghorbani M, Zarkoob S. Epidemiology of primary dysmenorrhea in Kerman,

Iran. Medical Journal of Islamic Republic of Iran 1994, 8:167-171.

15. Janghorbani M. Acute effect of cigarette smoking on fasting serum glucose

level in non-diabetic male smokers. Hamdard Medicus 1996; XXXIX:82-86.

16. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of

5

coronary heart disease among married non-smoking women. Medical Journal of

Islamic Republic of Iran 1997; 11:203-208.

17. Janghorbani M, Parvin F. Prevalence of overweight and thinness in high-school

girls in Kerman, Iran. Int J Obesity 1998, 22:629-633.

18. Aali BS, Janghorbani M. Epidemiology of preeclampsia in pregnant women

referred to Shahid Bahonar Hospital of Kerman, 1994. Journal of Kerman

University of Medical Sciences 1997; 4:20-25.

19. Fekri AR, Janghorbani M. Late cutaneous complications in chemical warfare

victims in Kerman province. Journal of Kerman University of Medical Sciences

1995; 2:108-119.

20. Sotodehnejad AR, Janghorbani M. Epidemiology of burns in Kerman: Analysis

of 1000 cases. Journal of Kerman University of Medical Sciences 1995; 2:128-

134.

21. Saryazdi S, Janghorbani M. Prevalence of diaper rush and influencing factors

in children under 2 years of nursery schools in Kerman, 1994. Iranian Journal of

Dermatology 1997; 1:24-29.

22. Janghorbani M, Nakhai HR. Effect of passive smoking during pregnancy on

weight, length and cranial circumference at birth in Kerman, Iran. Medical

Journal of Islamic Republic of Iran 1998;.12:31-36.

23. Ahmadi A, Janghorbani M. Evaluation of the growth of full-term Kermanian

neonates in the first month of life. Journal of Kerman University of Medical

Sciences 1997; 4:51-60.

24. Ahmadi A, Janghorbani M. Prevalence of obesity and leanness in primary-

school children in Kerman, Iran. Journal of Hamadan University of Medical

Sciences 1998; 6:15-24.

25. Janghorbani M, Ahmadi A. Validity of anthropometric measurements in

detection of low birth weights neonate in Kerman, Iran. Journal of the Faculty of

Medicine, Shahid Beheshti University of Medical Sciences 1999; 23:83-91.

26. Zhianpour M, Janghorbani M. How to give a paper or be a chairperson? Journal

of Ghazvin University of Medical Sciences 1999; 2:65-70.

27. Janghorbani M, Hiatbakhsh M, Ebrahimi A. Long terms effects of mustard gas

on pulmonary function tests in chemical warfare victims in Kerman, Iran. Journal

of the Faculty of Medicine, Shahid Beheshti University of Medical Sciences

6

1998; 22:9-17.

28. Janghorbani M. Assessing the design, conducts, presentation and statistical

content of medical studies. Journal of the Faculty of Medicine, Shahid Beheshti

University of Medical Sciences 1997; 21:18-24.

29. Zhianpour M, Janghorbani M, Latif A. Ultrasonographic measurements of the

normal kidney, liver, spleen, gallbladder and head of pancreas among radiology

department attenders. Hamdard Medicus 1998; XLI:73-82.

30. Janghorbani M, Akhavan-Mahdavi, Masoudi HR. The relationship between

ABO blood group and Rh factor with dental caries in soldiers of a military base

in Kerman. Journal of Kerman University of Medical Sciences 1996; 3:87-91.

31. Janghorbani M. Effect of Islamic fasting on body weight, blood pressure, serum

lipids, electrolytes, blood cell count and certain serum biochemical variables in

males. Journal of Kerman University of Medical Sciences 1995; 2:183-192.

32. Janghorbani M, Zhianpour M, Tabatabaiee HR. Diagnosis and prognosis

disclosure to dying adult cancer patients, part 1. physician attitude. Journal of

Kerman University of Medical Sciences 1994; 1:12-17.

33. Janghorbani M, Hamzehiee-Moghadam A, Kachoiee H. Epidemiology of non-

fatal stroke in Southeastern, Iran. Iranian Journal of Medical Sciences 1996;

21:135-139.

34. Janghorbani M, Farsi F. Epidemiology of pregnancies with unknown last

menstrual period. Journal of Kerman University of Medical Sciences 1995; 2:61-

65.

35. Foroudnia F, Janghorbani M. Characteristics of the inner city road traffic

casualties in Kerman during 1994. Journal of Kerman University of Medical

Sciences 1996; 3:35-42.

36. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of

coronary heart disease among married non-smoking women. Journal of Islamic

Republic of Iran 1997; 11:203-208.

37. Habibi-Khorasani AR, Janghorbani M, Darabi MR. Comparison of bronchial

brushing, washing and forceps biopsies in diagnosis of bronchogenic carcinoma.

Journal of Kerman University of Medical Sciences 1994; 1:58-64.

38. Janghorbani M, Nakhai HR. Effect of passive smoking during pregnancy on

weight, length and cranial circumference at birth in Kerman, Iran. MJIRI 12:31-

7

36; 1998.

39. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for cataract

among diabetes clinic attenders. Ophthalmic Epidemiology . 2000; 7:13-25. IF

1.25

40. Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family adults on

respiratory health of children in Kerman, Iran. Archive of Iranian Medicine;

1999; 2:1231-135.

41. Janghorbani M, Moazenzadeh M, Ebadzadeh MR. Relationship between age

and gender, and site and type of myocardial infarction and distribution of pain.

Hamdard Medicus ;2000; XLIII (2):79-87.

42. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for

proliferative retinopathy and association with blindness among diabetes clinic

attenders. Ophthalmic Epidemiology 2000; 7:225-41. IF 1.25

43. Janghorbani M, Jones RB, Murray KJ, Allison AP. Incidence of and risk

factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic

Epidemiology; 2001; 8:309-325. IF 1.25

44. Janghorbani M. Statistical guideline for contributing to medical journals.

Iranian Journal of Endocrinology and Metabolism; 2001; 3:57-70.

45. Lam TH, Janghorbani M, Fan S, Fielding R. Voluntary HIV antibody testing

amongst youth in Hong Kong. International Journal of STD & AIDS 2003,

14:132-138. IF 1.51

46. Lam TH, Janghorbani M, Hedley AJ, Ho SY, McGhee SM, Chan B. Public

opinion on smoking ban in restaurant and predicted effect on patronage in Hong

Kong. Tobacco Control, 2002 11:195-200. IF 2.42

47. Janghorbani M, Amini M, Ghanbari H, Safaie H.. Incidence of and risk factors

for diabetic retinopathy in Isfahan, Iran.. Ophthalmic Epidemiology; 2003;

10:81-95. IF 1.25

48. Janghorbani M, Ho SY, Lam TH, Janus ED. Prevalence and correlates of

alcohol use: a population-based study in Hong Kong. Addiction 2003; 98:215-

224 . IF 3.1

49. Janghorbani M, Lam TH. Sexual Media use by young adults in Hong Kong:

Prevalence and associated factors. Archive of Sexual Behavior 2003; 32 (6):545-

553. IF 2.29

8

50. Janghorbani M, Sadeghinia A, Asilian A, Mohammadzadeh Z.Primary results

of topical dairy extract (MJ1) versus intralesionally-administered meglumine

anitmonate for treatment of cutaneous leishmaniasis in Isfahan, Iran: a

randomized controlled clinical trial. Hamdard Medicus 2003; XLVI: 53-58..

51. Zhianpour M, Janghorbani M. Effect of clinical information on brain CT scan

interpretation: a blinded double crossover study. Medical Journal of Islamic

Republic of Iran; 2003; 13(3):173-177.

52. Habibi-Khorasani, Janghorbani M, Gozashti H, Samareh-Fekri M. Prevalence

of asthma in elementary school children in Kerman in 1999. Journal of Kerman

University of Medical Sciences. 2002; 9:184-193.

53. Janghorbani M (editorials). Epidemiology of sever acute respiratory syndrome

(SARS). Journal of Research in Medical Sciences. 2003, 8: 1-7.

54. Janghorbani M. Commentary: Assessment of rapid clinical response in acute

manic patients treating with oral loading sodium valproate. Journal of Research

in Medical Sciences. 2003, 8: 30-1.

55. Janghorbani M. Commentary: Where is cut-off point between volume of

euthyroid and enlarged thyroid? Journal of Research in Medical Sciences. 2003,

8: 73-74.

56. Janghorbani M, Ho SY, Lam TH, Janus ED. Association between total and

beverage-specific alcohol intake and obesity and fat distribution.: a population-

based study in Hong Kong. Alcohol Research 2003; 8(6):263-270.

57. Janghorbani M, Garak-Yaraghi M, Sherkat R, Izadi S, Rafiee-Moghadam B.

Anti-cardiolipin antibodies and risk of coronary heart disease. Hamdard

Medicus, 2005; XLVIII:107-111.

58. Aminoroaya A, Janghorbani M, Ramezani M, Haghighi S, Amini M. Does

bromocriptine improve glycemic control of obese type 2 diabetes? Hormone

Research. 2004; 62:55-59.

59. Janghorbani M, Amini M.Cataract in type 2 diabetes in Isfahan, Iran: Incidence

and risk factors. Ophthalmic Epidemiology; 2004; 11 (5): 347-358. IF 1.25

60. Janghorbani M, Taghdisi MT, Vingard E . Public opinion on smoking ban in

restaurant in Isfahan, Iran. Archive of Iranian Medicine, 2004; 7:260-266.

61. Aminoroaya A, Janghorbani M, Amini M. Comparison of the effect of

pentoxifylline and captopril on proteinuria in patients with type 2 diabetes

9

mellitus. Nephron Clinical Practice. 2005; 99:73-77.

62. Janghorbani M, Stenhouse E, Jones RB, Millward A. Is neighbourhood

deprivation a risk factor for gestational diabetes mellitus? Diabetic Medicine

2006; 23:313-317. IF 2.73

63. Janghorbani M, Sharifirad GR. Completed and attempted suicide in Ilam, Iran

(1995-2002): Incidence and associated factors. Archive of Iranian Medicine,

2005; 8:119-126.

64. Janghorbani M, Stenhouse E, Jones RB, Millward A. Gestational diabetes

mellitus in Plymouth, UK: prevalence, seasonal variation and associated factors.

The Journal of Reproductive Medicine 2006; 51:128-134.

65. Janghorbani M, Amini M. Coronary heart disease in type 2 diabetes mellitus in

Isfahan, Iran: prevalence and risk factors. Acta Cardiologica; 2006; 61:13-20.If

0.64

66. Cooper S, Janghorbani M, Cooper G. A decade of in-hospital resuscitation:

Outcomes and prediction of survival? Resuscitation 2006; 68:231-237. IF 1.76

67. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan,

Iran: Incidence and risk factors. Diabetes Research and Clinical Practice 2005;

70:71-80. IF 1.24

68. Janghorbani M, Stenhouse E, Millward A, Jones RB. Neighborhood

deprivation and preterm birth in Plymouth, UK. The Journal of Maternal-Fetal

and Neonatal Medicine; 2006; 19:85-91.

69. Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V.

Comparison of the effect of topiramate and sodium valporate in migraine

prevention. Headache 2005; 46:642-648. IF 2.46

70. Ashtary F, Janghorbani M, Chitsaz A, Reisi M, Bahrami A. A randomizes

double blind trial of bromocriptine efficacy in non—fluent aphasia after stroke.

Neurolgy 2006; 66:914-6. IF 5.21

71. Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of betaferon,

avonex and rebif in treatment of relapsing-remitting multiple sclerosis. Acta

Neurologica Scandinavica 2006; 113:283.

72. Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes

mellitus and risk of hip fracture: The Nurses Health Study. Diabetes Care 2006;

29:1573-8. IF 7.07

10

73. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtary F. Prevalence of

multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27:39-44. IF 1.39

74. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi, F,

Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran:

Prevalence and risk factors. Acta Neurologica Scandinavica 2006; 114:384-91.

75. Janghorbani M. Impact factor: What is impact factor. Resaech in Medicine

2005; 29:117-121.

76. Janghorbani M, Jones RB, Nelder R. Neighborhood deprivation and excess

coronary heart disease mortality and hospital admissions in Plymouth, UK: an

ecological study. Acta Cardiologica; 2006; 61:313-320.

77. Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G,

Rexrode KM. Prospective study of type 1 and type 2 diabetes and risk of stroke

subtypes: The Nurses' Health Study.Diabetes Care. 2007 ; 30:1730-35.

78. Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari AR, Alikhani S,

Mahdavi AR. First nationwide survey of prevalence of overweight, underweight,

and abdominal obesity in Iranian adults. Obesity (Silver Spring) 2007; 15

(11):2797-808.

79. Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E.

Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and

seasonal variation. Acta Neurologica Scandinavica 2008; 117 (2): 117-121.

80. Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of interferon

beta products and azathioprine in the treatment of relapsing –remitting multiple

sclerosis. Journal of Neurology 2007; 254(12):1723-8.

81. Safaei H, Janghorbani M, Aminorroaya A, Amini M. Lavastatin effects on

bone mineral density in post menopausal women with type 2 diabetes mellitus.

Acta Diabetologica 2007; 44:76-82.

82. Janghorbani M, Van Dam R, Willett WC, Hu F. Systematic review of type 1

and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;

166(5):495-505.

83. Janghorbani M, Amini M, Gouya MM, Delavari AR, Alikhani S, Mahdavi

AR. Association of body mass index and abdominal adiposity with educational

level in Iranian adults. Obesity and Metabolism-Milan 2007; 3:183-190.

84. Janghorbani M, Rexrode KM, Logroscino G. Letter to the Editor - Prospective

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Janghorbani+M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Hu+FB%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Willett+WC%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Li+TY%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Manson+JE%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Logroscino+G%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Rexrode+KM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Janghorbani+M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Rexrode+KM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Logroscino+G%22%5BAuthor%5D

11

study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses'

Health Study. Response to Tuttolomondo et al. Diabetes Care 2007; 30:2115.

85. Janghorbani M, Amini M. Metabolic syndrome in type 2 diabetes mellitus in

Isfahan, Iran: prevalence and risk factors. Metabolic Syndrome and Related

Disorders; 2007; 5 (3): 243-254.


AR. Nationwide survey of prevalence and risk factors of prehypertension and

hypertension in Iranian adults. Journal of Hypertension 2008; 26:419-426.

87. Safaei H, Amini M, Janghorbani M. The effect of HMG-CoA Reductase

inhibitor (Lovastatin) on bone mineral density (BMD) in postmenopausal women

with type 2 diabetes. Iranian Journal of Endocrinology & Metabolism 1384;

26(7): 142-135.

88. Motamedi B, Janghorbani M, Eftekhari. Prevalence of cesarean section and

some determinant factors in Kerman. Journal of Medical Faculty Guilan

University of Medical Sciences 1379;34-33(9): 95-88.

89. Zhianpour M, Janghorbani M. Diagnostic accuracy of chest X-ray and

appearance of bronchogenic carcinoma. Journal of Medical Faculty Guilan

University of Medical Sciences. 1378;30-29(8): 27-21.

90. Amini M, Janghorbani M. Diabetes and impaired glucose regulation in first

degree relatives of patients with type 2 diabetes in Isfahan, Iran: Prevalence and

risk factors. The Review of Diabetes Studies; 2007; 4:169.76.

91. Janghorbani M, Pourabdian S. ABO Blood Group and Risk of Overweight,

Underweight, and Obesity. Obesity and Metabolism- Milan; 2007; 4:106-109.

92. Janghorbani M, Nakhai-Pour HR. Evidence on beneficial effects of statins on

osteoporosis in diabetic women inconclusive. Review of Endocrinology March

2008; 9:26-29.

93. Adibi A, Janghorbani M, Shayganfar S, Amini M. First-degree relatives of

patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver

disease. Rev Diabet Stud. 2007; 4(4):236-41.


AR. Gender Differential in the Association of Body Mass Index and Abdominal

Obesity with Prehypertension and Hypertension in Iranian Adults. Obesity and

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Adibi%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Janghorbani%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Shayganfar%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Amini%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

12

Metabolism- Milan 2008; 4:169-176.

95. Shaygannejad V, Janghorbani M, Ashtari F, Afsharznjzni H, Zakizade N.

Effects of rivastigmine on memory and cognition in multiple sclerosis. Canadian

Journal of Neurological Sciences 2008; 35:476-481.

96. Siavash M, Janghorbani M, Gheshlaghi F, Adeli SH, Saljoughi M, Moradi F,

Majidinezhad M. A Case Series of Abuse of a New Opioid Combination,

Norjizak. Journal of Addictive Diseases 2009; 28:180-185.

97. Chitsaz A, Janghorbani M, Shaygannejad V, Ashtari F, Heshmatipour M,

Freeman F. Sensory complaints of the upper extremities in multiple sclerosis:

relative efficacy of nortriptyline and transcutaneous nerve stimulation. The

Clinical Journal of Pain 2009; 25:281-285.

98. Janghorbani M, Sheikhi Mehrabadi A, Pourabdian S. The prevalence and

correlate of hearing loss in drivers in Isfahan, Iran. Archive of Iranian Medicine

2009, 12(2): 128-34.

99. Janghorbani M, Amini M. Pattern and predictors of long-term weight change in

patients with type 2 diabetes mellitus. Annals of Nutrition and Metabolism 2009;

54 (2):111-118.

100. Amini M, Janghorbani M. Comparison of Metabolic Syndrome with Glucose

Measurement for Prediction of Type 2 Diabetes: the Isfahan Diabetes Prevention

Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews; 2009,

3:84-89.

101. Aminorroaya, A, Janghorbani, M, Amini M, Hovsepian S, Tabatabaei A,

Fallah Z. Prevalence of Thyroid Dysfunction in an Iodine-Sufficient Area in Iran.

Archive of Iranian Medicine 2009; 12:262-70.

102. Amini M, Janghorbani M. A risk score for prediction of type 2 diabetes: the

Isfahan Diabetes Prevention Study. Obesity and Metabolism 2009; 5: 13-19.

103. Izadi M, salehi H, chinikar S, Mostafavizadeh K, Darvishi M, Jonaidi N,

Ranjbar R, Khorvash F, Bidar R, Ataee B, Heidari M, Janghorbani M. A

Geographical Distribution Survey on CCHF Positive Antibody Bovine's of

Isfahan Province in 1383-1384. Journal of Military Medicine 2007; 2(9): 97-102.

104. Janghorbani M, Amini M. Diabetes Risk Among First-Degree Relatives of

Patients with Type 2 Diabetes in Isfahan, Iran. Obesity and Metabolism 2009;

5:114-120.

13

105. Janghorbani M, Amini M. Comparison of Fasting Glucose with Post-Load

Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes:

The Isfahan Diabetes Prevention Study. The Review of Diabetic Studies 2009;

6:117-123.

106. Janghorbani M, Amini M, Rezvanian H, Gouya MM, Delavari AR, Alikhani

S, Mahdavi AR. ASSOCIATION OF BODY MASS INDEX AND

ABDOMINAL OBESITY WITH MARITAL STATUS IN IRANIAN ADULTS.

Arch Iran Med. 2008;11:274-81.

107. Danesh A, Janghorbani M, Mohammadi B. Effects of zinc supplementation

during pregnancy on pregnancy outcome in women with history of preterm

delivery. A double-blind randomized, placebo-controlled trial. J Matern Fatal

Neonatal Med. 2010; 23 (5):403-408.

108. Janghorbani M, Amini M. Progression to impaired glucose metabolism in

first degree relatives of patients with type 2 diabetes in Isfahan, Iran.

Diabetes/Metabolism Research and Reviews 2009; 25:748-755.

109. Janghorbani M, Amini M. Normalization of Glucose Intolerance in First-

Degree Relatives of Patients with Type 2 Diabetes. Diabetes Research and

Clinical Practice 2010, 88(3):295-301.

110. Shaygannejad V, Janghorbani M, Savoj MR, Ashtari F. Effects of adjunct

glucosamine sulfate on relapsing-remitting multiple sclerosis progression:

Preliminary findings of a randomized, placebo-controlled trial. Neurological

Research 2010; 32(9):981-5.

111. Janghorbani M, Amini M. Comparison of Body Mass Index with Abdominal

Obesity Indicators and Waist-to-Stature Ratio for Prediction of Type 2 Diabetes:

The Isfahan Diabetes Prevention Study. Obesity Research & Clinical Practice

2010; 4:e25-e32.

112. Janghorbani M, Amini M. Predictors of switching to insulin from non-insulin

therapy in patients with type 2 diabetes. Journal of Diabetes research and Clinical

Practice 2011; 92:111-117.

113. Pourabdian S, Janghorbani M, Khoubei J, Tajvidi M, Mohebbi I.

Relationship between high risk occupation particularly aromatic amines exposure

and bladder cancer in Isfahan: a case-control study. The Journal of Urmia

University of Medical Sciences 2010; 21 (2):124-134.

14

114. Janghorbani M, Amini M. Comparison of Systolic and Diastolic Blood

Pressure with Pulse Pressure and Mean Arterial Pressure for Prediction of Type 2

Diabetes: The Isfahan Diabetes Prevention Study. Endokrynologia Polska 2011;

62:324-30.

115. Janghorbani M, Enjezam B. Review of epidemiology of gestational diabetes

in Iran. Journal of Isfahan Medical School 2010; 28:225-240.

116. Janghorbani M, Amini M. Incidence of Type 2 Diabetes by HbA1c and OGTT:

The Isfahan Diabetes Prevention Study. Acta Diabetologica 2010: in press.

117. Janghorbani M, Amini M, Salehi-Marzijarani M. Weight Change, Blood Pressure,

Lipids and Glycemic Control among Patients with Type 2 Diabetes. Annals of Nutrition

and Metabolism 2011; 58:141-149.

118. Karami M, Janghorbani M, Dehghani AR, Riahinejad M. Orbital Doppler

Evaluation of Blood Flow Velocities in Optic Neuritis. Korean Journal of

Ophthalmology 2011; in press.

119. Karami M, Janghorbani M, Dehghani AR, Riahinejad M. Orbital Doppler

Evaluation of Blood Flow Velocities in Optic Neuritis. Iranian Journal of

Ophthalmology 2011; 23:11-18.

120. Daraei A, Salehi R, Salehi M, Emami MH, Jonghorbani M,

Mohamadhashem F, Tavakoli H. Effect of rs6983267 polymorphism in the 8q24

region and rs4444903 polymorphism in EGF gene on the risk of sporadic

colorectal cancer in Iranian population. Med Oncol. 2011 May 13. [Epub ahead

of print].

121. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh

GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global

Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group

(Body Mass Index). National, regional, and global trends in body-mass index

since 1980: systematic analysis of health examination surveys and

epidemiological studies with 960 country-years and 9·1 million participants.

Lancet. 2011; 377(9765):557-67.

122. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ,

Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M; Global Burden of

Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol).

National, regional, and global trends in serum total cholesterol since 1980:

systematic analysis of health examination surveys and epidemiological studies

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Daraei%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Salehi%20R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Salehi%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Emami%20MH%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Jonghorbani%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mohamadhashem%20F%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tavakoli%20H%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Finucane%20MM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Stevens%20GA%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Cowan%20MJ%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Danaei%20G%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lin%20JK%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Paciorek%20CJ%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Singh%20GM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Singh%20GM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gutierrez%20HR%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lu%20Y%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bahalim%20AN%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Farzadfar%20F%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Riley%20LM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ezzati%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Global%20Burden%20of%20Metabolic%20Risk%20Factors%20of%20Chronic%20Diseases%20Collaborating%20Group%20(Body%20Mass%20Index)%22%5BCorporate%20Author%5D



http://www.ncbi.nlm.nih.gov/pubmed/21295846



15

with 321 country-years and 3·0 million participants. Lancet. 2011;

377(9765):578-86.

123. Khalili GR, Jonghorbani M, Sajedi P, Ahmadi GH. Effects of Adjunct

Intrathecal Magnesium Sulfate to Bupivacaine for Spinal Anesthesia: A

Randomized, Double-Blind Trial in Patients Undergoing Lower Extremity

Surgery. Journal of Anesthesia 211; 25:892-897.

124. Janghorbani M, Amini M. Associations of Hip Circumference and Height

with Incidence of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Acta

Diabetologica 2011 (in press).

125. Karami Nogourani M, Janghorbani M, Kowsari Isfahan R, Hosseini Beheshti

M. Effects of Chewing Different Flavored Gums on Salivary Flow Rate and pH.

International Journal of Dentistry 2012; 2012:569327.

126. Janghorbani M, Amini M. Incidence of metabolic syndrome and its risk

factors among type 2 diabetes clinic attenders in Isfahan, Iran. ISRN

Endocrinology 2012:167318.

127. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A.

Effect of dairy consumption on weight and body composition in adults: a

systematic review and meta-analysis of randomized controlled clinical trials. Int

J Obes 2012; 36:1485-1493.

128. Janghorbani M, Amini M. Metabolic syndrome in first degree relatives of

patients with type 2 diabetes: incidence and risk factors. Diabetes & Metabolic

Syndrome: Clinical Research & Reviews 2011; 5:201-206.

129. Shaygannejad V, Janghorbani M, Ashtari F, Dehghan H. Effects of adjunct

low-dose vitamin D on relapsing-remitting multiple sclerosis progression:

Preliminary findings of a randomized, placebo-controlled trial. Multiple

Sclerosis International 2012 2012:452541.

130. Janghorbani M, Amini M. Normal Fasting Plasma Glucose and Risk of Pre-

diabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Review of

Diabetic Studies 2012; 8:490-498.

131. Mohammad Hassan Emami, Soheila Kouhestani, Somayeh Karimi,

Abdolmahdi Baghaei, Mohsen Janghorbani, Nahid Jamali, and Ali

Gholamrezae. Frequency of Celiac Disease in Adult Patients with Typical or





http://www.hindawi.com/25762941/








16

Atypical Malabsorption Symptoms in Isfahan, Iran. Gastroenterology Research

and Practice 2012, Article ID 106965, 6 Pages

132. Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and

meta-analysis of insulin therapy and risk of cancer. Hormones and Cancer 212;

3:137-146.

133. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati

M , Mehrabi Y, Zahedi-Asl S, Ainy S, Allahverdian S, Amirshekari G, Arshadi

A, Askari S, Atifeh M, Azimzadeh I, Azizi T, Daneshpour M, Emami

H, Eskandari F, Fakhimi T, Ghanbili MJ, Gahazi AA, Habibian S, Hajibabai

M, Hajiour R, Harati H, Heydarian P, Hosseini F, Hosseinpanah F, Janghorbani

M, Kalhor Y, Majid M, Malekafzai H, Mehrabani H, Mirhosseii M, Moeini

AS, Mojarad M, Nemati K, Noori A, Padyab M, Rahmani M, Saadat N, Saadati

N, Sadegholvad M, Sarbazi N, SarrafZadeh A, Shafiei N, Shiva N, Tohidi

M, Zabetian A. Prevention of non-communicable disease in a population in

nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10:

art. No. 5.

134. Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H. Comparison of the

effect of aspirin and amantadin for the treatment of fatigue in multiple sclerosis:

a randomized, blinded, crossover study. Neurological Research 212 (in press).

135. Nogourani MK, Janghorbani M, Khadem P, Jadidi Z, Jalali S. A 12-month

clinical evaluation of pit-and-fissure sealants placed with and without etch-and-

rinse and self-etch adhesive systems in newly-erupted teeth. J Appl Oral Sci.

2012 Jun; 20(3):352-6.

136. Janghorbani M, Momeni F, Dehghani M. Hip circumference, height and risk

of type 2 diabetes: systematic review and meta-analysis. Obesity Reviews 212;

13:1172-81.

137. Janghorbani M, Amini M. Patterns and Predictors of Long-Term Glycemic

Control in Patients with Type 2 Diabetes. ISRN Endocrinology 2012;

2012:526824. doi: 10.5402/2012/526824. Epub 2012 Oct 16.

138. Danesh A, Janghorbani M, Khalatbari S. Effects of Antenatal Corticosteroids

on Maternal Serum Indicators of Infection in Women at Risk for Preterm

http://www.scopus.com/authid/detail.url?authorId=35519137100&eid=2-s2.0-63049113000







mailto:[email protected]




















































http://www.scopus.com/source/sourceInfo.url?sourceId=4700151726&origin=recordpage




17

Delivery: A Randomized Trial Comparing Betamethasone and Dexamethasone.

Journal of Research in Medical Sciences 2012; 7: 911-917.

139. Janghorbani M, Amini M. Glycated hemoglobin as a predictor for metabolic

syndrome in an Iranian population with normal glucose tolerance. Metabolic

Syndrome and Related Disorders 2012; 10:430-36.

140. Khalili GR, Jonghorbani M, Saryazdi H, Emaminejad A. Effect of

preemptive and preventive acetaminophen on postoperative pain score: a

randomized, double-blind trial in patients undergoing lower extremity surgery.

Journal of Clinical Anesthesia 2013; 25 (30:188-192.

141. Janghorbani M, Amini M. Comparison of glycated hemoglobin with fasting

plasma glucose in definition of glycemic component of the metabolic syndrome

in an Iranian population. Diabetes & Metabolic Syndrome: Clinical Research &

Reviews 2012; 6:136-9.

142. Janghorbani M, Amini M. Incidence of metabolic syndrome and its risk

factors among type 2 diabetes clinic attenders in Isfahan, Iran. Endokrynol Pol.

2012; 63(5):372-80.

143. Karami M, Janghorbani M, Dehghani AR, Khaksar K, Kaviani A. Orbital

Doppler Evaluation of Blood Flow Velocities in Patients with Diabetic

Retinopathy. Review of Diabetic Studies 212; 9: 104-111.

144. Shaygannejad V, Janghorbani M, Vaezi A, Haghighi S, Golabchi K,

Heshmatipour M. Comparison of the effect of baclofen and transcutaneous

electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.

Neurological Research 2013 in press.

145. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN,

McIntire RK, Gutierrez HR, Cowan M, Paciorek CJ, Farzadfar F, Riley L, Ezzati

M for the Global Burden of Metabolic Risk Factors of Chronic Diseases.

Collaborating Group (Body Mass Index). National, regional, and global trends in

adult overweight and obesity prevalences. Popul Health Metr. 2012; 10(1):22.



18

146. Janghorbani M, Piraei E. Association between air pollution and preterm birth

among neonates born in Isfahan, Iran. Journal of Research in Medical Sciences

2013; 18:875-881.

147. Keykha M, Janghorbani M, Amini M. Prevalence and Risk Factors of

Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of

Patients with Type II Diabetes. Journal of Kerman University of Medical

Sciences 2013; 20:115-128.

148. Salamat MR, Salamat AH, Abedi I, Janghorbani M. Relationship

between weight, body mass index and bone mineral density in men

referred for dual-energy X-ray absorptiometry scan in Isfahan, Iran.

Journal of Osteoporosis 2013; 2013:205963.

149. Shahmansouri, Janghorbani M, Salehi Omran A, Karimi AA, Noorbala AA,

Arjmandi A, Nikfam ُ S. Effects of a psychoeducation intervention on fear and

anxiety about surgery: Randomized trial in patients undergoing coronary artery

bypass grafting. Psychology Health and Medicine; 2014; 19 (4):375-83.

150. Janghorbani M, Abbasi A. Comparison of Pregnancy Outcomes of Low

Molecular Weight Heparin with Unfractionated Heparin in the Treatment of

Recurrent Abortion Secondary to Antiphospholipid Syndrome. J Babol Univ

Med Sci 213; 15:17-23.

151. Janghorbani M, Adineh HA, Amini M. Finnish Diabetes Risk Score to

Predict Type 2 Diabetes: the Isfahan Diabetes Prevention Study. Diabetes

Research and Clinical Practice 2013; 102:202-209.

152. Janghorbani M, Mansourian M, Hosseini E. Systematic review and meta-

analysis of age at menarche and risk of type 2 diabetes. Acta Diabetologica 2014

(in press).

153. Farnam F, Janghorbani M, Merghati E. Vaginismus and its correlates in an

Iranian clinical sample. International Journal of Impotence Medicine: The

Journal of Sexual Medicine 2014; in press.

154. Salari M, Janghorbani M, Etemadifar M, Dehghani AR, Razmjoo H,

Naderian GA. Effects of vitamin D on retinal nerve fiber layer in vitamin D

deficient patients with optic neuritis: Preliminary findings of a randomized,

placebo-controlled trial. Journal of Research in Medical Sciences 2014 in press.

19

155. Janghorbani M, Momeni F, Mansourian M. Systematic review and meta-

analysis of air pollution exposure and risk of diabetes. European Journal of

Epidemiology 2014 (in press).

156. Janghorbani M, Amini M. Low-density lipoprotein cholesterol and metabolic

syndrome in an Iranian high-risk population. Diabetes & Metabolic Syndrome:

Clinical Research & Reviews 2014, in press.

157. Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, Yaran

M. Hepatitis A seropositivity among newly admitted medical students of Isfahan,

Kermanshah, and Hamedan: A seroprevalence study. J Res Med Sci. 2014

Mar;19 (Suppl 1):S9-S12.

158. Farnam F, Janghorbani M, Merghati-Khoei E, Raisi F. Compare the

effectiveness of PLISSIT and Sexual Health Models on women’s sexual

problems in Tehran, Iran: a randomized controlled trial. Journal of Sexual

Medicine. 2014, in press

Presentations


cataract among diabetes clinic attenders. 7th Iranian Congress of

Ophthalmology 14-17 March 1998, Isfahan, Iran.


diabetic retinopathy in diabetic clinic attenders. 7th Iranian Congress of

Ophthalmology 14-17 March 1998, Isfahan, Iran

3. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk

of coronary heart disease among married non-smoking women. The first

eastern Mediterranean Congress on Preventive Cardiology and 10th

Annual Iranian Congress of cardiovascular disease May 2-5, 1997,

Isfahan, Iran.

4. Janghorbani M, Moazenzadeh M, Ebadzadeh MR. Relationship

between age and gender, and site and type of myocardial infarction and

distribution of pain. 3rd International Heart Health Conference 29

August - 2 September 1998 Singapore.

5. Janghorbani M, Parvin F. Prevalence of overweight and thinness in

high-school girls in Kerman, Iran. IV International Epidemiological

association Eastern Mediterranean Regional Scientific Meeting

November 18-21, 1998, Tunis Tunisia.

6. Janghorbani M, Ahmadi A. Validity of anthropometric measurements

in detection of low birth weights neonate in Kerman, Iran. Emirates

International Congress on Perinatology November 11-13, 1998 Abu

Dhabi, United Arab Emirates.



20

7. Janghorbani M, Nakhai HR. Effect of passive smoking during

pregnancy on birth weight, length at birth and cranial circumference in

Kerman, Iran. 3rd IEA/EMR Scientific Meeting October 22-25, 1997,

Beirut Lebanon.


of coronary heart disease among married non-smoking women. 10th

Word Conference on Tobacco or Health 24-28 August 1997, Beijing

China.

9. Janghorbani M, Nakhai HR. Effect of passive smoking during

pregnancy on birth weight, length at birth and cranial circumference in

Kerman, Iran. 10th World Conference on Tobacco or Health 24-28

August 1997, Beijing China.


of coronary heart disease among married non-smoking women. 4th

International Conference on Preventive Cardiology June 29- July 3 1997

Montreal Canada.

11. Janghorbani M, Jones RB. Incidence of and risk indicators for diabetic

retinopathy in diabetic clinic attenders. XIV International Scientific

meeting of the International Epidemiological Association August 27-30

1996, Nagoya Japan.

12. Hyatbakhsh M, Janghorbani M, Hajipour S. Relationship between

serum alaninaminotransferase and diabetes mellitus. From Science to

Practice Congress: 20 universally of Medical School, Kerman

University of Medical Sciences, October 31-November 2, 1998,

Kerman, Iran.

13. Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family

adults on respiratory health of children in Kerman, Iran. From Science

to Practice Congress: 20 universally of Medical School, Kerman

University of Medical Sciences, October 31-November 2, 1998,

Kerman, Iran.

14. Pourseidi B, Janghorbani M, Ebrahimi A. Relationship between

bladder evacuation methods and urinary infection in spinal cord injuries

in Kerman. From Science to Practice Congress: 20 universally of

Medical School, Kerman University of Medical Sciences, October 31-

November 2, 1998, Kerman, Iran.

15. Janghorbani M. The incidence and factors influencing incidence of

low birth weight in Kerman. From Science to Practice Congress: 20

universally of Medical School, Kerman University of Medical Sciences,

October 31-November 2, 1998, Kerman, Iran.

16. Janghorbani M. An epidemiological study of tuberculosis in children

under 10 years of age. Tuberculosis Symposium November 17-21,1984,

Tabriz, Iran.

17. Janghorbani M. Diagnosis & prognosis disclosure to adult dying

cancer patients,: Part I. Physician attitude. The 10th Asian Pacific

Cancer Conference August 20-23, Beijing China 1991.

21

18. Janghorbani M. Diagnosis & prognosis disclosure to adult cancer

patients,: Part 2. Patients attitude. 13th Asian Pacific Cancer Conference

August 20-23, Penang Malaysia 1996.

19. Janghorbani M, Hedley AJ, Zhianpour M, Jones RB Gilmur WH.

Blood pressure components as predictor of ischaemic heart disease

mortality in west of Scotland. 2nd Iranian hypertension Seminar,

November 28-30, 1988, Yazd, Iran.

20. 15th International Cancer Congress August 16-22, 1990 Hamburg,

Germany.

21. Janghorbani M, Jones RB, Hedley AJ. Single casual blood glucose as

a predictor of later development of diabetes in a middle-aged

population. XIIth Scientific Meeting of the International

Epidemiological Association. August 5-9, 1990, Los Angeles,

California USA.

22. Janghorbani M, Jones RB, Hedley AJ. Single casual blood glucose as

a predictor of later development of diabetes in a middle-aged

population. First Iranian Diabetes Congress November 16-18 , 1993,

Yazd, Iran.

23. Janghorbani M. Principles of epidemiology. 10th International

Congers of Geographic Medicine of Shiraz University of Medical

Sciences & 6th Iranian Congress of Infectious and Tropical Disease.

November 10-13, 1997, Shiraz, Iran.

24. Janghorbani M, Jones RB, Allison S. Incidence of and risk indicators

for cataract among diabetes clinic attenders. International Congress on

Preventive Ophthalmology. July 25-27, 1998, Amsterdam, Netherlands.


adults on respiratory health of children in Kerman, Iran.5th IEA Eastern

Mediterranean Regional Scientific Meeting. Bahrain: October 23-25,

2000.

26. Janghorbani M. Effect of smoking habits of father on health of

children and wife. First National Congress on Preventive Medicine and

Public Health. Kermanshah, Iran, November 22-23, 2000.

27. Janghorbani M. Prevalence of hypertension among teachers, Kerman,

Iran. The 5th International Conference on Preventive Cardiology. May

27-31, 2001 Osaka, Japan.

28. Daneshvar – Farzanegan P, Baghaiee M, Janghorbani M, Karimi J.

Prevalence of cutaneous leishmaniasis health center attenders in

Borkhar and Mimeh. The 10th Iranian Congress on Infectious Disease

and Tropical Medicine 5-9 Jan. 2002. Iran University of Medical

sciences,Tehran.


adults on respiratory health of children in Kerman, Iran.11th Conference

of the International Society for Environmental Epidemiology (ISSE_

and 9t Conference of the International Society of Exposure Analysis

(ISEA), Sept. 5-8, 1999, Athens, Greece.

30. Daneshvar – Farzanegan P, Baghaiee M, Janghorbani M, Karimi J,

Mtovali-Emami M. Distribution of cutaneous leishmaniasis in Borkhar

22

and Mimeh. 2nd Congress on Preventive Medicine and Public Health.

Kermanshah, Iran, November 6-8, 2001.

31. Janghorbani M, Garak-Yaraghi M, Sherkat R, Izadi S, Rafiee-

Moghadam B. Anti-cardiolipin antibodies and risk of coronary heart

disease. The 3rd Mediterranean Congress on Heart Health, Cardiology

Update 2002, and WHO Workshop on “Secondary Prevention of

Myocardial Infarction”. Giza, Egypt 10-13 April, 2002.

32. Janghorbani M, Lam TH, Fan S, Fielding R. Voluntary HIV antibody

testing amongst youth in Hong Kong. International Conference, Impact

of Global Issues on Women and Children, 16-21 February 2003,

Bangkok, Thailand.

33. Janghorbani M, Lam TH, Hedley AJ, Ho SY, McGhee SM, Chan B.

Public opinion on smoking ban in restaurant and predicted effect on

patronage in Hong Kong. 12 World Conference on Tobacco or Health,

3-8 August 2003, Helsinki, Finland.

34. Janghorbani M. International Training program in occupational safety

and health and development. The Swedish National Institute for

working life. Swedish International Development Cooperation Agency

(SIDA). First course period. Stockholm Sweden Sept 24- Oct. 26, 2001.


and health and development. The Swedish National Institute for

Working Life. Swedish International Development Cooperation Agency

(SIDA). Second course period. Captown, South Africa May 24- 30,

2002.


and health and development . The Swedish National Institute for

Working Life. Swedish International Development Cooperation Agency

(SIDA). Third course period. Casablanca, Morroco, Sept 10- 20, 2003.

37. Janghorbani M. Asian AMEA Inaugural Symposium. Medical

Education in the 21st Century. June 21 & 22, 2001, Hong Kong, China.

38. Janghorbani M, Lam TH, Fan S, Fielding R. Voluntary HIV antibody

testing amongst youth in Hong Kong. IEA South East Asia Congress of

Epidemiology, 24-27 February 2002, Jhansi (U.P.) India.

39. Janghorbani M, Sharifirad GR. Epidemiology of completed and

attempted suicide in Ilam, Iran (1992-2002). Third Conference on

Epidemiological Longitudinal Studies in Europ, CELSE-3, 22-25

September 2004, Bristol UK.

40. Janghorbani M. Epidemiology of colorectal cancer. The 3rd Regional

Conference of Asian pacific Organization for Cancer Prevention

(APOCP): GI Cancer Control. 25-27 April 2005 , Zibakenar, Rasht,

Iran.

41. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in

Isfahan, Iran: Incidence and risk factors. The XVIIth IEA World

Congress of Epidemiology. Epidemiology & Equity in Health:

Methodological Challenges & Strategies for 21th Century. Imperial

Queen’s Park Hotel. 21-25 August 2005, Bangkog, Thailand.

23

42. Janghorbani M, Jones RB, Nerlder R. Neighbourhood deprivation

and excess coronary heart disease mortality and hospital admission in

Plymouth, UK: an ecological study. The XVIIth IEA World Congress

of Epidemiology. Epidemiology & Equity in Health: Methodological

Challenges & Strategies for 21th Century. Imperial Queen’s Park Hotel.

21-25 August 2005, Bangkog, Thailand.

43. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A,

Izadi, F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in

Isfahan, Iran: Prevalence and risk factors. The first world congress on

Controversies in Obesity, Diabetes and Hypertension (CODHy) October

25-29, 2006, Estrel Hotel, Berlin, Germany.

44. Janghorbani M, Taghdisi MT, Vingard E . Public opinion on smoking

ban in restaurant in Isfahan, Iran. !3th Word Conference on tobacco OR

Health. Building capacity for a tobacco-free world. July 12-15 2006,

Washington DC, USA.

45. Janghorbani M. Epidemiology of multiple sclerosis. The 3rd

Internation Congress on Multiple Sclerosis. November 16-17, 2006,

Isfahan, Iran.

46. Shaygannejad V, Janghorbani M, Etemadifar M, Maghzi AH.

Comparison of interferon beta products and azathioprine in treatment of

relapsing remitting multiple sclerosis. The 3rd Internation Congress on

Multiple Sclerosis. November 16-17, 2006, Isfahan, Iran.

47. Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari AR,

Alikhani S, Mahdavi AR. FIRST NATIONWIDE SURVEY OF

PREVALENCE OF OVERWEIGHT, UNDERWEIGHT, AND

ABDOMINAL OBESITY IN IRANIAN ADULTS. !5th European

Congress on Obesity. April 22-25, 2007, Budapest, Hungary.

48. Janghorbani M, Amini M. Prevalence of diabetes and impaired

glucose regulation in first degree relatives of patients with type 2

diabetes. 1st National Congress of Endocrine and Metabolism Updates.

October 31 to November 1, 2007, Isfahan, Iran.

49. Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari AR,

Alikhani S, Mahdavi AR. FIRST NATIONWIDE SURVEY OF

PREVALENCE OF OVERWEIGHT, UNDERWEIGHT, AND

ABDOMINAL OBESITY IN IRANIAN ADULTS. 1st National

Congress of Endocrine and Metabolism Updates. October 31 to

November 1, 2007, Isfahan, Iran.

50. Janghorbani M, Adibi A, Shayganfar S, Amini M. first degree

relatives of patients with type 2 diabetes mellitus and risk of non-

alcoholic fatty liver diseae. 1st National Congress of Endocrine and

Metabolism Updates. October 31 to November 1, 2007, Isfahan, Iran.

51. Shaygannejad, V; Janghorbani, M; Ashtari, F, et al. Comparative

frequency of word finding impairment in relapsing-remitting multiple

sclerosis patients, and a control group

Conference Information: 12th Congress of the European-Federation-

of-Neurological-Societies, Date: AUG 23-26, 2008 Madrid SPAIN

http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=V1KECG67iM4blMh@hDP&page=1&doc=4&colname=WOS



24

Source: EUROPEAN JOURNAL OF NEUROLOGY Volume: 15

Pages: 147-147 Published: 2008.

52. ): Shayganmejad, V; Janghorbani, M; Ashtari, F, et al. Does

rivastigmine improve memory in multiple sclerosis?

Conference Information: 23rd Congress of the European-Committee-

for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual

Conference of Rehabilitation in MS, Date: OCT 11-14, 2007 Prague

CZECH REPUBLIC

Source: MULTIPLE SCLEROSIS Volume: 13 Pages: S127-S127

Published: 2007.

53. Hedley, AJ; McGhee, SM; Repace, J, Wong TW, Yu MYS, Chan

AYW, Lam TH, Lo PCK, Tsang M, Wong LC, Chan ALN, Ng ESL,

Janghorbani M. .Analysis of dose, exposure, and risk for 104 Hong

Kong catering workers exposed to secondhand smoke (SHS) at work

only

Source: EPIDEMIOLOGY Volume: 13 Issue: 4 Pages: S231-S232

Published: JUL 2002

Meeting Abstract: 848

54. Janghorbani, M. Critical appraisal of systematic reviews

Conference Information: 4th Regional Congress on Medical Journals

in Eastern Mediterranean Region November 5-7, 2008 Bahrain

55. Title: Effects of glucosamine sulfate on multiple sclerosis progression: a

randomized, placebo-controlled trial

Author(s): Shaygannejad, V; Ashtari, F; Janghorbani, M

Conference Information: 13th Annnual Meeting of the Amer-Comm-

for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the

European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th

Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-

Sclerosis, Date: SEP 17-20, 2008 Montreal CANADA

Source: MULTIPLE SCLEROSIS Volume: 14 Pages: S178-S178

Published: 2008.

56. Janghorbani, M, Amini M. Comparison of metabolic syndrome with

glucose measurement for prediction of type 2 diabetes: the isfahan

Diabetes Prevention Study.

Conference Information: 2nd Iranian Congress of Endocrine and

Metabolism Updates April 22-24, 2009 Isfahan, Iran

57. Janghorbani, M, Amini M. Effect of gender and height on the oral

glucose tolerance test: the isfahan Diabetes Prevention Study.



58. Janghorbani, M, Aminorroaya, A, Amini M. Prevalence of

hypothyroidism in iodine replete area in Iran.



59. Janghorbani, M, Amini M. Pattern and predictors of long-term weight

change in patients with type 2 diabetes mellitus.






http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=W17oMiipgoik8ahF166&page=1&doc=1&colname=WOS

http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=W17oMiipgoik8ahF166&page=1&doc=1&colname=WOS

25



60. Roya Sherkat, M. Garak-Yaraghi, M. Janghorbani, Shiva Izadi, B.

Rafiee-Moghadam and J. Hasheminia. Anti-Cardioliphin Antibodies

and Risk of Coronary Heart Disease. 9th Annual Meeting, Federation of

Clinical Immunology Societies 2009. Clinical Immunology. Volume

131, Supplement 1, 2009, Page S147.

61. M. Janghorbani, M. Amini, M. Gouya, A. Delavari, S. Alikhani, A.

Mahdavi. NATIONWIDE SURVEY OF PREVALENCE AND RISK

FACTORS OF PREHYPERTENSION AND HYPERTENSION IN

IRANIAN ADULTS. 77th Congress of the European Atherosclerosis

Society, April 26–29, 2008, Istanbul, Turkey. Atherosclerosis

Supplements, Volume 9, Issue 1, May 2008, Page 213.

62. Mohsen Janghorbani, Atoosa Adibi Sanaz Shayganfar, Masoud

Amini. Nondiabetic first degree relatives of patients with Type 2

diabetes and risk of non alcoholic fatty liver disease. Diabetes Research

and Clinical Practice, Volume 79, Supplement 1, February 2008, Page

S102.

63. Janghorbani M, Amini M. COMPARISON OF METABOLIC

SYNDROME WITH GLUCOSE MEASUREMENT FOR

PREDICTION OF TYPE 2 DIABETES: THE ISFAHAN DIABETES

PREVENTION STUDY. Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) October 30 - November 2, 2008,

Barcelona, Spain.

64. Mohsen Janghorbani. Pattens and predictors of long-term weight

change in patients with type 2 diabetes mellitus. Annals of Nutrition and

Metabolism 2009; 55 (Suppl 1): 349. 19th International Congress of

Nurition. October 4-9, 2009, Bangkok, Thailand.

65. Sheikhi A, Janghorbani M, Soleimani B. Relation between obesity

and depression using structural equation modeling. Stochastic Modeling

Techniques and Data Analysis International Conference (SMTDA2010),

8-11 June 2010, Chania Crete Greece.

66. Janghorbani M, Amini M. Long-term impact of weight change on

blood pressure, lipids and metabolic control among patients with type 2

diabetes. Longitudinal and Life Course Studies 2010 1 (3) Supplement

:84. The 5th conference of Epidemiological Longitudinal Studies in

Europe (CELSE2010) 13-15 October 2010, Paphos Cyprus.

67. Janghorbani M. Diabetes and cancer. 1st International and 3rd Iranian

Congress of Endocrine and Metabolism Updates. 30 Nov. – 3 Dec.

2010. Isfahan University of Medical sciences, Iran.

68. Janghorbani M. Principles of screening. 1st Advance screening in

medicine. 24 may -26 May 2011. Mashad, Azad Islamic University.

69. Janghorbani M. Incidence of Type 2 Diabetes by HbA1c and OGTT:

The Isfahan Diabetes Prevention Study. IEA World Congress of

Epidemiology 7 – 11 August 2011 Edinburgh International Conference

Centre, Scotland, UK.

http://www.sciencedirect.com/science/journal/15216616

http://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=%23TOC%236740%232009%23998689999.8998%231082072%23FLA%23&_cdi=6740&_pubType=J&view=c&_auth=y&_acct=C000052608&_version=1&_urlVersion=0&_userid=1403370&md5=4335ae5800c5028c7285f7d63b315ba5

http://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=%23TOC%236740%232009%23998689999.8998%231082072%23FLA%23&_cdi=6740&_pubType=J&view=c&_auth=y&_acct=C000052608&_version=1&_urlVersion=0&_userid=1403370&md5=4335ae5800c5028c7285f7d63b315ba5

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6X14-4SG5Y30-12D&_user=1403370&_coverDate=05%2F31%2F2008&_alid=912182659&_rdoc=3&_fmt=high&_orig=search&_cdi=7232&_sort=d&_docanchor=&view=c&_ct=29&_acct=C000052608&_version=1&_urlVersion=0&_userid=1403370&md5=09fee9e3ef0b8acbb63c6dd1495edb12



http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T5Y-4SHGH4C-95&_user=1403370&_coverDate=02%2F29%2F2008&_alid=912182659&_rdoc=4&_fmt=high&_orig=search&_cdi=5015&_sort=d&_docanchor=&view=c&_ct=29&_acct=C000052608&_version=1&_urlVersion=0&_userid=1403370&md5=6f0f7caec18990bffe7f1a01d5fb23b0

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T5Y-4SHGH4C-95&_user=1403370&_coverDate=02%2F29%2F2008&_alid=912182659&_rdoc=4&_fmt=high&_orig=search&_cdi=5015&_sort=d&_docanchor=&view=c&_ct=29&_acct=C000052608&_version=1&_urlVersion=0&_userid=1403370&md5=6f0f7caec18990bffe7f1a01d5fb23b0

26

70. Janghorbani M. Weight Change and Blood Pressure, Lipids and

Glycemic Control among Patients with Type 2 Diabetes. IEA World

Congress of Epidemiology 7 – 11 August 2011. Edinburgh International

Conference Centre, Scotland , UK.

71. Janghorbani M. SYSTEMATIC REVIEW AND META-ANALYSIS

OF INSULIN THERAPY AND RISK OF CANCE. 7th World Congress

of Prevention of Diabetes and Its Complications 11-14 November 2012.

Madrid, Spain.

72. Janghorbani M., Mansourian M, Hosseini E. Systematic review and

meta-analysis of age at menarche and risk of type 2 diabetes. 2014

Seoul International Congress of Endocrinology and Metabolism 15-18

May 2014, Seoul, South Korea.

B. Translator of Following Books:

1. Hulley SB, Cummings S (ed.), Janghorbani M, Sadeghi-Hassanabadi A

(translator).Designing Clinical Research. Jehad Daneshgahi Publications

Tehran 1995.

2.Beaglehole R, Bonita R, Kjellstrom T (eds.), Janghorbani M, Zhianpour M

(translator).Basic Epidemiology. Ministry of Health and Medical Education

Publication, Tehran 1992.

3. Fletcher RH, Fletcher SW, Wagner EH (eds.), Janghorbani M, Sadeghi-

Hassanabadi A (translator). Clinical Epidemiology: The essentials. 1st edition

Shiraz University of Medical Sciences Publication Shiraz, 1995.

4. Freedman GD (ed.), Janghorbani M, Sadeghi-Hassanabadi A (translator).

Primer of Epidemiology. Jehad Daneshgahi Publications Tehran 1993.

5. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn

Epidemiology An Introductory Text. Kerman Cultural Services Publications

1st edition Kerman 1994.



2nd edition Kerman 1994.

7. Austin MG (Eds.) Janghorbani M, Zhianpour M (translator). Young’s

Learning Medical Terminology. 1st ed., Jehad Daneshgahi Publications

Tehran 1990.

8. Austin MG (eds.), Janghorbani M, Zhianpour M (translator). Young’s

Learning Medical Terminology. 2nd ed., Jehad Daneshgahi Publications

Tehran 1996.

9. Fletcher RH, Fletcher SW, Wagner EH (eds.), Janghorbani M, Sadeghi-

Hassanabadi A (translator). Clinical Epidemiology: The essentials.2nd edition,

Shiraz University of Medical Sciences Publication Shiraz, 1999.

10. Abramson JH (Eds.) Sadeghi-Hassanabadi A Janghorbani M (translator)

Survey Methods in Community Medicine:Epidemiological studies, programme

evaluation, clinical trials. 4th edition. Shiraz University of Medical Sciences

Publication Shiraz, 2000.

27

11.Greenberg RS, Daniels SR, Flanders WD, Eley JW, Borin JR. Medical

Epidemiology. Isfahan University of Medical Sciences Press, Isfahan, 2000.

12. Last MJ. A Dictionary of Epidemiology. Isfahan University of Medical

Sciences Press, Isfahan, 2001.

13. Giesecke J. Modern infectious disease epidemiology. Office of Preventive

and Control of Disease. Ministry of Health, Treatment and Medical Education

Tehran 2001.



3rd edition Kerman 2002.

15. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman T

(ed.), Janghorbani M (translator). Designing Clinical Research. 2nd edition,

Isfahan University of Medical Sciences Press, Isfahan, 2003 .



4th edition Kerman 2005.





Epidemiology. An Introductory Text. Kerman Cultural Services Publications


Editor of Following Books:

1. Azizi F, Janghorbani M and Hatami H (eds.). Epidemiology and Control of

Common Diseases in Iran. Nashreh Eshtiagh,Tehran 2001.

2. Janghorbani M (contributor): Last MJ. A dictionary of Epidemiology .4th ed.

Oxford University Press. 2001.

3. Janghorbani M. Textbook of Public Health. 1st revision.

4. Azizi F, Janghorbani M and Hatami H (eds.). Epidemiology and Control of

Common Diseases in Iran. Khosravi,Tehran 2010.

5. Janghorbani M. Textbook of Public Health. 3rd revision, Ketab Arjomand, 2013.

Member of Board of Consultants of Following Journals:

1. Journal of Islamic Republic of Iran

2. Journal of Kerman University of Medical Sciences, Iran.

3. Journal of Babol University of Medical Sciences, Iran.

6. Journal of Ghazvin University of Medical Sciences, Iran.

7. Journal of Research in Medical Sciences, Isfahan, Iran

Member of Editorial Board of Following Journals:

1. Journal of Research in Medical Sciences, Isfahan, Iran

2. Journal of Babol University of Medical Sciences, Iran

28

3. Dental Journal of Isfahan University of Medical Sciences.

4. Editor of Journal of Research in Medical Sciences, Isfahan, Iran

Member of the Following Societies and Meetings

1. International Epidemiological Association

2. The Royal Institute of Public Health & Hygiene and the Society of Public Health

3. Iranian Society of Family Planning

4. The International Association for Study of Lung Cancer (ex-member)

5. American Public Health Association (ex-member)

6. The Global Environmental Epidemiology Network

7. Member of the Regional Organising Committee of the 4th International

Epidemiological Association/Eastern Mediterranean Region Scientific meeting, Tunis,

Tunisia 1998.

8. Member of the Organising Committee of the From Science to Practice Congress,

Kerman, Iran 1998.

9. Member of the Regional Organising Committee of the 5th International

Epidemiological Association/Eastern Mediterranean Region Scientific meeting,

Menama, Bahrain, 2000.

10. Member of American Diabetes Association (ex-member).

11. Member of the Scientific Committee of the First National Congress on Preventive

Medicine and Public Health. Kermanshah, Iran, November 22-23, 2000.

12. Member of the board of Iranian Epidemiological Association.

13. Member of the Scientific Committee of the Second National Congress on

Preventive Medicine and Public Health. Kermanshah, Iran, November 6-9, 2001.

14. Member of the Regional Organising Committee and Scientific committee of the

6th International Epidemiological Association/Eastern Mediterranean Region

Scientific meeting, Ahwaz, Iran December 9-11, 2003.

Date post:	25-Dec-2019
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

Mohsen Janghorbani Professor of Epidemiology Department …...5 coronary heart disease among married...

Documents